Related Experiment Video
Updated: Feb 14, 2026
02:34
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
2.0K
Autoantibodies in Chronic Obstructive Pulmonary Disease
Lifang Wen1, Susanne Krauss-Etschmann2,3, Frank Petersen2
1Xiamen-Borstel Joint Laboratory of Autoimmunity, Medical College of Xiamen University, Xiamen, China.
Frontiers in Immunology
|February 10, 2018
Summary
Autoimmunity, specifically autoantibodies, may play a role in the development of chronic obstructive pulmonary disease (COPD). Research suggests these antibodies are present in COPD patients and can cause COPD-like symptoms in animal models.
Area of Science:
- Pulmonary Medicine
- Immunology
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading cause of death globally, characterized by irreversible airflow limitation.
- Major etiological factors include inhaled toxins like cigarette smoke, but pathogenesis remains incompletely understood.
- Emerging evidence links COPD to autoimmunity, with autoantibodies found in patient sera and animal models.
Purpose of the Study:
- To provide an advanced overview of the link between autoimmunity and COPD.
- To critically discuss the role of autoantibodies in COPD pathogenesis.
Main Methods:
- Review of existing clinical and animal model studies on COPD and autoimmunity.
- Analysis of autoantibody presence and correlation with COPD phenotypes.
- Evaluation of experimental evidence for autoimmunity mediating COPD-like symptoms.
Main Results:
- Autoantibodies are detected in the sera of COPD patients.
- Certain autoantibodies correlate with specific COPD disease phenotypes.
- Autoimmunity against pulmonary antigens contributes to COPD-like symptoms in animal models.
Conclusions:
- Autoimmunity represents a novel perspective for understanding COPD pathogenesis.
- Autoantibodies are implicated in the development and progression of COPD.
- Further research into the autoimmune component of COPD is warranted.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.3K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K